C49.21
Malignant neoplasm of connective and soft tissue of right lower limb, including hip
Clinical Classification Guidelines
Medical Intelligence & Overview
C49.21 refers to a malignant tumor that develops in the connective tissues and soft tissues of the right lower limb, including the hip region. This medical condition involves abnormal and uncontrolled growth of cancerous cells originating from tissues such as fat, muscle, blood vessels, nerves, or connective tissue structures. The disease is classified under the ICD-10 code C49.21, used for healthcare documentation and billing purposes, and requires prompt medical attention for accurate diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations that cause abnormal cell growth Previous radiation exposure to the area History of certain hereditary cancer syndromes Chronic inflammation or injury in the affected limb Environmental exposure to carcinogenic substances
Key Symptoms: Persistent lump or swelling in the thigh or hip area Pain or tenderness in the affected limb Limited or restricted movement or mobility Night pain or pain that worsens over time Weakness or numbness if nerves are involved Unexplained weight loss or fatigue in advanced cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing the malignant tumor involves a combination of medical evaluations including physical examination, imaging tests, and biopsy procedures. Common diagnostic steps include:
Treatment Protocols: Treatment options for this type of tumor are tailored to the individual based on the tumor’s size, location, stage, and overall health. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C49.21 a billable ICD-10 code?
Yes, C49.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C49.21?
Clinical documentation must specify the nature of Malignant neoplasm of connective and soft tissue of right lower limb, including hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference